About: http://webisa.webdatacommons.org/340034759

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	Novartis already has its foot in the door of the hospital-based infections market, through the marketing of Cubist Pharmaceuticals' cyclic lipopeptide, Cubicin??, in the EU and other countries.
http://www.w3.org/ns/prov#wasQuotedFrom	genengnews.com